Free press releases distribution network?

Agency / Source: Synowledge PV Services India (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Synowledge Announces Record Growth in 2011 – Anticipates Sustained Progress in 2012 - Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies - Synowledge.com
Synowledge Announces Record Growth in 2011 – Anticipates Sustained Progress in 2012

 

PRZOOM - /newswire/ - Stamford, CT, United States, 2012/01/31 - Synowledge is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies - Synowledge.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Synowledge, LLC, a market leader in pharmacovigilance, regulatory affairs, and related IT services for pharmaceutical, medical device, and biotechnology companies, is pleased to announce 2011 as a year of record growth, with plans to continue the momentum into 2012.

In 2011, Synowledge added over 15 clients to its list of global clientele, including key multi-year case processing partnerships with a Top 5 Biotech and a Top 25 Pharma. With a volume of over 60,000 serious and non-serious adverse events processed in 2011, Synowledge’s case volumes have increased significantly and Synowledge forecasts that this growth will continue in 2012. In addition to the increased case volumes, Synowledge has advanced its aggregate reporting, signal detection, literature search, and safety system maintenance services.

As a result of significant aggregate growth, Synowledge announced the May 2011 opening of Synowledge GmbH in Frankfurt, Germany to strengthen its European project management and sales functions. Additionally, Synowledge opened a state of the art delivery & training campus in Mysore, India in October 2011. The Mysore facility provides augmented delivery functions and offers full business continuity for drug safety and IT activities at Synowledge’s Bangalore Delivery Center. Moving into 2012, Synowledge has also announced plans to open an office in Japan to better serve the Asia-Pacific market.

“The combination of expanded partnerships with industry leaders, steady growth in various areas of drug safety, and our extension into regulatory affairs services solidified Synowledge’s position as a market leader in 2011,” says David Ingraham, Director of Strategic Accounts. “With a growing network of offices and facilities spanning three continents and clients across the globe, we are confident that 2012 will be another year of significant progress. We look forward to expanding our global footprint by continuing to provide life sciences companies with value added services that increase efficiency, productivity, and compliance with regulatory agencies, while significantly reducing costs.”

About Synowledge

Synowledge (synowledge.com) is a global provider of drug safety, regulatory affairs and related IT solutions to small, mid and large sized pharmaceutical and biotechnology companies. Our comprehensive outsourcing solutions combine the unique strengths of both onshore and offshore services to meet our clients’ needs. With more than 15 years of industry experience, our core team members have worked with leading pharmaceutical, biotech, medical device, and health care provider organizations. Synowledge is headquartered in Stamford, CT, USA with operation facilities located in Ohio, the United Kingdom, Germany, and India.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Synowledge PV Services India (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Synowledge Announces Record Growth in 2011 – Anticipates Sustained Progress in 2012

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Sheshadri - Synowledge.com 
+91 80 22448841 d.ingraham[.]ymail.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Synowledge PV Services India (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Synowledge PV Services India (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom

Visit  BizJobs.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today